OICHARTS
8 AMThe 8 AM report →

WST

West Pharmaceutical Services, Inc. · XNYS · 131 sessions on record
$370.76▼ −5.87 · −1.6%from $376.63 the session before · Sep 30, 2026 close · end of day
Open
$375.35
High
$376.19
Low
$370.13
Day's range
$6.11.6% of the previous close
VWAP
$371.83close −0.29% from it
Volume, shares
471K0.77× the 20-session average
Traded, $
$175.2M
Trades
14.4K33 shares per trade
Previous close
$376.63−5.87 to the close
Market cap
$26.09Bat the close of Sep 30
Day range10% of the way up
$370.13$376.19
52-week range90% of the way up
$240.16 Apr 1$386.00 Jul 23

−3.9% from the high · +54% from the low

Options

No listed options on WST

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
WST close over the last 126 sessions, with S&P 500 rebased to the first close252.74329.92407.09axis spans 61%S&P 500WSTApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 61 percent.

Quarterly results

consolidated · latest filed Jul 23, 2026 · SEC filings

Revenue $872.3M, +14% on a year earlier; profit $154.0M, +17% in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of WST on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Jul 23$872.3M▲ +14%$154.0M▲ +17%2.15▼ −7.7%S&P 500 +0.1% · −7.8 pp
Mar 2026filed Jul 23$844.9M▲ +21%$138.8M▲ +55%1.92▼ −7.7%S&P 500 +0.1% · −7.8 pp
Dec 2025filed Feb 17$805.0M▲ +7.5%$132.1M▲ +1.5%1.82—not reached
Sep 2025filed Oct 23$804.6M▲ +7.7%$140.0M▲ +2.9%1.92—not reached
Jun 2025filed Jul 23$766.5M▲ +9.2%$131.8M▲ +18%1.82▼ −7.7%S&P 500 +0.1% · −7.8 pp
Mar 2025filed Jul 23$698.0M▲ +0.37%$89.8M▼ −22%1.23▼ −7.7%S&P 500 +0.1% · −7.8 pp
Dec 2024filed Feb 18$748.8M▲ +2.3%$130.1M▼ −5.0%1.78—not reached
Sep 2024filed Oct 23$746.9M▼ −0.07%$136.0M▼ −16%1.85—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of WST on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025$3.07B▲ +6.3%$493.7M▲ +0.20%6.79
FY24to Dec 2024$2.89B▼ −1.9%$492.7M▼ −17%6.69
FY23to Dec 2023$2.95B▲ +2.2%$593.4M▲ +1.3%7.88
FY22to Dec 2022$2.89B▲ +2.0%$585.9M▼ −11%7.73
FY21to Dec 2021$2.83B▲ +32%$661.8M▲ +91%8.67

Fundamentals

consolidated · filings to Jun 2026 · close $370.76 on Sep 30

WST trades at 47 times trailing earnings, 8.7 times book value, revenue +12% over twelve months, a 0.12% dividend yield, market cap $26.09B.

Valuation
Market cap
$26.09Bon Sep 30
Price to earnings
47consolidated · four quarters to Jun 2026
Trailing EPS
$7.81diluted · consolidated · four quarters to Jun 2026
Price to book
8.7consolidated · balance sheet to Jun 2026
Book value a share
$42.49consolidated · balance sheet to Jun 2026
Debt to equity
0.07borrowings over equity · consolidated · balance sheet to Jun 2026
Return on equity
19%trailing profit over average equity · consolidated
Dividend yield
0.12%$0.44 a share in 365 days
Price to sales
7.8market cap over revenue, four quarters to Jun 2026
Shares outstanding
70.4Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$3.33Bfour quarters to Jun 2026
Revenue growth, 12 months
▲ +12%against the twelve months before
Revenue 3-year CAGR
▲ +5.1%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
$564.9Mfour quarters to Jun 2026
Profit growth, 12 months
▲ +16%against the twelve months before
Profit 3-year CAGR
▲ +2.9%trailing twelve months against the twelve months 3 years earlier · consolidated

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 190% of shares, BlackRock, Inc. the largest at 19%, VANGUARD CAPITAL MANAGEMENT LLC 13% and VANGUARD PORTFOLIO MANAGEMENT LLC 11%, as filed for the quarter to Jun 2026.

Held by 13F managers
190%of shares outstanding
Shares held
135M−1.3% on Mar 2026 among managers filing both
Managers holding
778705 a quarter earlier
Largest holder
19%BlackRock, Inc.
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of WST
ManagerSharesOf outstandingValueChange on quarter
BlackRock, Inc.13.3M19%$4.78B−370K
VANGUARD CAPITAL MANAGEMENT LLC9.23M13%$3.31B−140K
VANGUARD PORTFOLIO MANAGEMENT LLC8.03M11%$2.88B−156K
FMR LLC7.15M10%$2.57B+4.65M
STATE STREET CORP6.7M9.5%$2.40B+110K
Artisan Partners Limited Partnership4.82M6.8%$1.73B−492K
Bank of New York Mellon Corp4.09M5.8%$1.47B−844K
GENERATION INVESTMENT MANAGEMENT LLP4.06M5.8%$1.46B−431K
GEODE CAPITAL MANAGEMENT, LLC3.81M5.4%$1.36B−18.4K
MORGAN STANLEY3.17M4.5%$1.14B+249K
Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

WST insider trades
InsiderTradeSharesPriceHeld after
Campbell Shane AldenOfficerwithheld for tax · May 12, 2026135$312.07613
Campbell Shane AldenOfficerexercised · May 12, 2026474—748
Campbell Shane AldenOfficerexercised · May 12, 2026296—358
Campbell Shane AldenOfficerwithheld for tax · May 12, 202684$312.07274
BUTHMAN MARK ADirectorgranted · May 4, 2026791$0.0044,309
Feehery William FDirectorgranted · May 4, 2026791$0.0032,519
FRIEL ROBERT FDirectorgranted · May 4, 2026791$0.005,513
HAUGEN JANET BRUTSCHEADirectorgranted · May 4, 2026791$0.002,373
Joseph MollyDirectorgranted · May 4, 2026791$0.004,398
Keller Deborah LDirectorgranted · May 4, 2026791$0.0011,560

Corporate actions

exchange records

Nothing upcoming on record; the last was a dividend of $0.22 a share, ex-date Jul 29, 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in dollars a share, splits as ratios
Corporate actions of WST, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord date
recent
Jul 29, 2026dividend$0.22—
Apr 29, 2026dividend$0.22—
Calendardividends by ex-date
Dividends in 365 days
$0.44a share · ex-dates inside the year
Last dividend
$0.22ex-date Jul 29, 2026

Price history

131 sessions on record · to Sep 30 · end of day

WST is +9.5% over 20 sessions against the S&P 500's +0.1%, 3.9% below its 52-week high, realised volatility 21% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $WST %S&P 500 %Difference pp
120 sessionssince Apr 9$258.53▲ +43%▲ +12%+31
60 sessionssince Jul 7$356.09▲ +4.1%▲ +2.0%+2.1
20 sessionssince Sep 1$338.66▲ +9.5%▲ +0.11%+9.4
5 sessionssince Sep 23$375.87▼ −1.4%▼ −0.67%−0.69
1 sessionsince Sep 29$376.64▼ −1.6%▼ −0.21%−1.3
Averages of the closeclose against each average
5-session average
$373.42close −0.71% from it
20-session average
$358.87close +3.3% from it
50-session average
$351.51close +5.5% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$9.12.5% of the close
Average day's range, 20
$8.52.3% of the close
Volume against 20 sessions
0.77×471K vs 610K average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
21%≈ ±1.3% a session · moved more than that on 6 of 20
Realised volatility, 60
25%≈ ±1.6% a session · moved more than that on 13 of 60
Beta to S&P 500, 60
0.14moved with S&P 500 on 36 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
11 up · 9 downof 20
Last 60 sessions
32 up · 28 downof 60
Best session, 250
▲ +13%Apr 23
Worst session, 250
▼ −7.7%Jul 24

West Pharmaceutical Services, Inc. is held by

1 headlines on WST

latest Sep 30, 2026 · links go to the publisher

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 42% of reported volume on Sep 30, 2026, against 55% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
WST daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 202675.2K177K42.4%
Sep 29, 2026130K244K53.1%
Sep 28, 202673.4K230K31.9%
Sep 25, 202683.6K174K48.1%
Sep 24, 2026117K338K34.6%
Sep 23, 2026112K348K32.1%
Sep 22, 2026157K317K49.5%
Sep 21, 2026103K193K53.6%
Sep 18, 2026137K191K72.1%
Sep 17, 2026142K210K67.5%

Filings

SEC EDGAR · newest first
WST SEC filings
FiledFormReport date
Sep 15, 20264Sep 11, 2026
Sep 10, 20264Sep 8, 2026
Sep 10, 20264Sep 8, 2026
Sep 10, 20263Aug 31, 2026
Aug 12, 20264Aug 11, 2026
Aug 6, 2026SCHEDULE 13G—
Jul 23, 202610-QJun 30, 2026
Jul 23, 20268-KJul 23, 2026
Jul 14, 20268-KJul 14, 2026
Jul 1, 20264Jun 30, 2026
Jun 1, 20268-KMay 31, 2026
May 20, 20268-K/AMay 7, 2026
May 14, 20264May 12, 2026
May 13, 2026SD—
May 11, 20268-KMay 7, 2026
May 7, 2026144—
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026
May 6, 20264May 4, 2026

About West Pharmaceutical Services, Inc.

SEC and exchange records
Company
West Pharmaceutical Services, Inc.
Exchange
XNYS
SEC CIK
105770
Sessions on record
131
Price source
End of day · delayed
Computed
1 Oct, 10:35 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.